No datasets match
  1. curatedBreastData::curatedBreastData_pData
    curatedBreastData_pData
  2. curatedCRCData::GSE11237_eset
    Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation.
    ExpressionSet
  3. curatedCRCData::GSE12225.GPL3676_eset
    Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis.
    ExpressionSet
  4. curatedCRCData::GSE12945_eset
    An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.
    ExpressionSet
  5. curatedCRCData::GSE13067_eset
    DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
    ExpressionSet
  6. curatedCRCData::GSE13294_eset
    DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
    ExpressionSet
  7. curatedCRCData::GSE14095_eset
    Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients.
    ExpressionSet
  8. curatedCRCData::GSE14333_eset
    Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.
    ExpressionSet
  9. curatedCRCData::GSE16125.GPL5175_eset
    Integrative approach for prioritizing cancer genes in sporadic colon cancer.
    ExpressionSet
  10. curatedCRCData::GSE17536_eset
    Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
    ExpressionSet
  11. curatedCRCData::GSE17537_eset
    Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
    ExpressionSet
  12. curatedCRCData::GSE17538.GPL570_eset
    Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
    ExpressionSet
  13. curatedCRCData::GSE18105_eset
    MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer.
    ExpressionSet
  14. curatedCRCData::GSE2109_eset
    Expression Project for Oncology (expO)
    ExpressionSet
  15. curatedCRCData::GSE21510_eset
    Clinical significance of osteoprotegerin expression in human colorectal cancer.
    ExpressionSet
  16. curatedCRCData::GSE21815_eset
    Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.
    ExpressionSet
  17. curatedCRCData::GSE24549.GPL5175_eset
    Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
    ExpressionSet
  18. curatedCRCData::GSE24550.GPL5175_eset
    Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
    ExpressionSet
  19. curatedCRCData::GSE2630_eset
    A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients.
    ExpressionSet
  20. curatedCRCData::GSE26682.GPL570_eset
    MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.
    ExpressionSet
  21. curatedCRCData::GSE26682.GPL96_eset
    MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.
    ExpressionSet
  22. curatedCRCData::GSE26906_eset
    Expression Profiles in Stage II Colon Cancer According to APC Gene Status.
    ExpressionSet
  23. curatedCRCData::GSE27544_eset
    Genome-wide profiling characterizes CRCs with genetic instability and specific routes to HLA class I loss and immunoescape
    ExpressionSet
  24. curatedCRCData::GSE28702_eset
    Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis.
    ExpressionSet
  25. curatedCRCData::GSE3294_eset
    Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
    ExpressionSet
  26. curatedCRCData::GSE33113_eset
    Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.
    ExpressionSet
  27. curatedCRCData::GSE39582_eset
    Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    ExpressionSet
  28. curatedCRCData::GSE3964_eset
    Deciphering cellular states of innate tumor drug responses.
    ExpressionSet
  29. curatedCRCData::GSE4045_eset
    Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.
    ExpressionSet
  30. curatedCRCData::GSE4526_eset
    Gene expression signature for recurrence in stage III colorectal cancers.
    ExpressionSet
  31. curatedCRCData::GSE45270_eset
    AMC tubular and serrated adenomas
    ExpressionSet
  32. curatedCRCData::TCGA.COAD_eset
    Comprehensive molecular characterization of human colon and rectal cancer.
    ExpressionSet
  33. curatedCRCData::TCGA.READ_eset
    Comprehensive molecular characterization of human colon and rectal cancer.
    ExpressionSet
  34. curatedCRCData::TCGA.RNASeqV2_eset
    Comprehensive molecular characterization of human colon and rectal cancer.
    ExpressionSet
  35. curatedCRCData::TCGA.RNASeqV2.READ_eset
    Comprehensive molecular characterization of human colon and rectal cancer.
    ExpressionSet
  36. curatedMetagenomicData::sampleMetadata
    Manually Curated Sample Metadata
  37. curatedMetagenomicData::sampleMetadata
    Manually Curated Sample Metadata
  38. curatedOvarianData::E.MTAB.386_eset
    Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.
    ExpressionSet
  39. curatedOvarianData::GSE12418_eset
    Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.
    ExpressionSet
  40. curatedOvarianData::GSE12470_eset
    Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
    ExpressionSet
  41. curatedOvarianData::GSE13876_eset
    Survival-related profile, pathways, and transcription factors in ovarian cancer.
    ExpressionSet
  42. curatedOvarianData::GSE14764_eset
    A prognostic gene expression index in ovarian cancer - validation across different independent data sets.
    ExpressionSet
  43. curatedOvarianData::GSE17260_eset
    Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.
    ExpressionSet
  44. curatedOvarianData::GSE18520_eset
    A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
    ExpressionSet
  45. curatedOvarianData::GSE19829.GPL570_eset
    Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
    ExpressionSet
  46. curatedOvarianData::GSE19829.GPL8300_eset
    Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
    ExpressionSet
  47. curatedOvarianData::GSE20565_eset
    A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
    ExpressionSet
  48. curatedOvarianData::GSE2109_eset
    IGC EXpression Project for Oncology
    ExpressionSet
  49. curatedOvarianData::GSE26193_eset
    miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
    ExpressionSet
  50. curatedOvarianData::GSE26712_eset
    A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
    ExpressionSet
  51. curatedOvarianData::GSE30009_eset
    Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
    ExpressionSet
  52. curatedOvarianData::GSE30161_eset
    Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
    ExpressionSet
  53. curatedOvarianData::GSE32062.GPL6480_eset
    High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    ExpressionSet
  54. curatedOvarianData::GSE32063_eset
    High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    ExpressionSet
  55. curatedOvarianData::GSE44104_eset
    COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
    ExpressionSet
  56. curatedOvarianData::GSE49997_eset
    Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
    ExpressionSet
  57. curatedOvarianData::GSE51088_eset
    POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    ExpressionSet
  58. curatedOvarianData::GSE6008_eset
    Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
    ExpressionSet
  59. curatedOvarianData::GSE6822_eset
    Classification of ovarian tumor samples
    ExpressionSet
  60. curatedOvarianData::GSE8842_eset
    Analysis of gene expression in early-stage ovarian cancer.
    ExpressionSet
  61. curatedOvarianData::GSE9891_eset
    Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    ExpressionSet
  62. curatedOvarianData::PMID15897565_eset
    Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
    ExpressionSet
  63. curatedOvarianData::PMID17290060_eset
    An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
    ExpressionSet
  64. curatedOvarianData::PMID19318476_eset
    Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
    ExpressionSet
  65. curatedOvarianData::TCGA_eset
    Integrated genomic analyses of ovarian carcinoma.
    ExpressionSet
  66. curatedOvarianData::TCGA.mirna.8x15kv2_eset
    Integrated genomic analyses of ovarian carcinoma.
    ExpressionSet
  67. curatedOvarianData::TCGA.RNASeqV2_eset
    Integrated genomic analyses of ovarian carcinoma.
    ExpressionSet
  68. curatedOvarianData::E.MTAB.386_eset
    Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.
    ExpressionSet
  69. curatedOvarianData::GSE12418_eset
    Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.
    ExpressionSet
  70. curatedOvarianData::GSE12470_eset
    Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
    ExpressionSet
  71. curatedOvarianData::GSE13876_eset
    Survival-related profile, pathways, and transcription factors in ovarian cancer.
    ExpressionSet
  72. curatedOvarianData::GSE14764_eset
    A prognostic gene expression index in ovarian cancer - validation across different independent data sets.
    ExpressionSet
  73. curatedOvarianData::GSE17260_eset
    Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.
    ExpressionSet
  74. curatedOvarianData::GSE18520_eset
    A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
    ExpressionSet
  75. curatedOvarianData::GSE19829.GPL570_eset
    Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
    ExpressionSet
  76. curatedOvarianData::GSE19829.GPL8300_eset
    Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
    ExpressionSet
  77. curatedOvarianData::GSE20565_eset
    A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
    ExpressionSet
  78. curatedOvarianData::GSE2109_eset
    IGC EXpression Project for Oncology
    ExpressionSet
  79. curatedOvarianData::GSE26193_eset
    miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
    ExpressionSet
  80. curatedOvarianData::GSE26712_eset
    A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
    ExpressionSet
  81. curatedOvarianData::GSE30009_eset
    Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
    ExpressionSet
  82. curatedOvarianData::GSE30161_eset
    Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
    ExpressionSet
  83. curatedOvarianData::GSE32062.GPL6480_eset
    High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    ExpressionSet
  84. curatedOvarianData::GSE32063_eset
    High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    ExpressionSet
  85. curatedOvarianData::GSE44104_eset
    COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
    ExpressionSet
  86. curatedOvarianData::GSE49997_eset
    Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
    ExpressionSet
  87. curatedOvarianData::GSE51088_eset
    POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    ExpressionSet
  88. curatedOvarianData::GSE6008_eset
    Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
    ExpressionSet
  89. curatedOvarianData::GSE6822_eset
    Classification of ovarian tumor samples
    ExpressionSet
  90. curatedOvarianData::GSE8842_eset
    Analysis of gene expression in early-stage ovarian cancer.
    ExpressionSet
  91. curatedOvarianData::GSE9891_eset
    Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    ExpressionSet
  92. curatedOvarianData::PMID15897565_eset
    Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
    ExpressionSet
  93. curatedOvarianData::PMID17290060_eset
    An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
    ExpressionSet
  94. curatedOvarianData::PMID19318476_eset
    Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
    ExpressionSet
  95. curatedOvarianData::TCGA_eset
    Integrated genomic analyses of ovarian carcinoma.
    ExpressionSet
  96. curatedOvarianData::TCGA.mirna.8x15kv2_eset
    Integrated genomic analyses of ovarian carcinoma.
    ExpressionSet
  97. curatedOvarianData::TCGA.RNASeqV2_eset
    Integrated genomic analyses of ovarian carcinoma.
    ExpressionSet
  98. HMP16SData::dictionary
    A data dictionary describing dbGaP metadata variables
  99. HMP16SData::dictionary
    A data dictionary describing dbGaP metadata variables
  100. lefser::zeller14
    Example dataset for lefser
    SummarizedExperiment
  101. lefser::zeller14
    Example dataset for lefser
    SummarizedExperiment
  102. MicrobiomeBenchmarkData::sampleMetadata
    sampleMetadata
  103. MicrobiomeBenchmarkData::sampleMetadata
    sampleMetadata
  104. MultiAssayExperiment::miniACC
    Adrenocortical Carcinoma (ACC) MultiAssayExperiment
    MultiAssayExperiment
  105. MultiAssayExperiment::miniACC
    Adrenocortical Carcinoma (ACC) MultiAssayExperiment
    MultiAssayExperiment
  106. TCGAutils::clinicalNames
    Clinical dataset names in TCGA
    CompressedCharacterList
  107. TCGAutils::diseaseCodes
    TCGA Cancer Disease Codes Table
  108. TCGAutils::sampleTypes
    Barcode Sample Type Table
  109. TCGAutils::clinicalNames
    Clinical dataset names in TCGA
    CompressedCharacterList
  110. TCGAutils::diseaseCodes
    TCGA Cancer Disease Codes Table
  111. TCGAutils::sampleTypes
    Barcode Sample Type Table